CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 4 Grant or award Chief Financial Officer acquired 93,322 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 64,395 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 1,200,000 shares at $12.50 ($15,000,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 46,619 shares (grant or award)
- 4 Open-market buy 10% owner bought 1,368,421 shares at $9.50 ($13,000,000)
- 4 Open-market buy 10% owner bought 1,050,000 shares at an average $8.76 ($9,202,668)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 3,200,000 shares at $4.25 ($13,600,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 12 · 223 filings